Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
H-biota Gyntima
- Development stage
- Unknown
- Lead developer
- AB-BIOTICS
- Modality
- Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
H-biota Gyntima is an oral probiotic dietary supplement developed by H-biota in collaboration with AB-Biotics (a Kaneka company) for the maintenance of female intimate and vaginal microbiota health. The active ingredient is the patented, human-derived probiotic strain *Lactobacillus gasseri* KABP 064 (CECT 30648). Taken orally, the strain is highly resilient, surviving gastrointestinal transit to successfully colonize the vaginal tract. Once established, it produces lactic acid to restore and maintain a healthy, low physiological vaginal pH, thereby supporting natural defense mechanisms against vaginal dysbiosis and common urogenital infections (such as bacterial vaginosis, aerobic vaginitis, and vulvovaginal candidiasis). It can be used as a daily supplement or as a supportive therapy alongside antibiotic or antifungal treatments.
- Brand names
- Gyntima BalanceH-biota Gyntima
- Other names
- L. gasseri CECT 30648L. gasseri KABP 064Lactobacillus gasseri CECT 30648Lactobacillus gasseri KABP 064Ейч-Биота Джинтима
Beyond the preview
Go deeper on H-biota Gyntima.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on H-biota Gyntima.